Genome-wide cfDNA sequencing in cancer patients

Labcorp appoints Dr. Deborah Ann Sesok-Pizzini as chief medical officer, Labcorp Diagnostics

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 19, 2021-- Labcorp , (NYSE: LH), a leading global life sciences company, announced today that Dr. Deborah Ann Sesok-Pizzini has been appointed Chief Medical Officer of Labcorp Diagnostics , following the retirement of Dr. Dot Adcock in April 2021 . Dr. Sesok-Pizzini assumed the role starting on January 11, 2021.

Media Statement: Labcorp political contributions

Labcorp does not make contributions to federal political candidates. 

Media Statement: Tracking mutations of the SARS CoV2

We have been regularly tracking mutations of the virus throughout the pandemic to determine the impact it would have on our PCR sensitivity. To date, we have not seen any impact. Our current capacity for PCR tests is 270k and we continue to operate with a 1-2 day turnaround. The only way to identify the strain is by sequencing, and we have research support underway that includes sequencing of the virus.

Labcorp to announce fourth quarter and full year 2020 financial results on February 11, 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 8, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, will release its fourth quarter and full year 2020 financial results before the market opens on Thursday, Feb. 11, 2021 , and then will host a conference call and webcast beginning at 9:00 a.m. ET to discuss the results. 

Labcorp awarded CDC contract to study variants of COVID-19 virus and improve public health response

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 7, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been awarded a contract from the Centers for Disease Control and Prevention ( CDC ) to provide genomic sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.

Brian Caveney, chief medical officer and president of Labcorp Diagnostics, named to Modern Healthcare's 100 Most Influential People in Healthcare

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that Dr. Brian Caveney, chief medical officer and president of Labcorp Diagnostics , was recognized by Modern Healthcare as one of the 100 most influential people in healthcare in 2020.

Labcorp is scheduled to virtually participate at the 39th annual J.P. Morgan Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 5, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12 at 8:20 a.m. (EST).